|
What does Oculus Innovative Sciences do?
Oculus Innovative Sciences is a commercial healthcare company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, which significantly reduces the need for antibiotics while reducing infections and accelerating healing. The Microcyn Technology addresses the need for improved solutions in multiple markets including dermatology, oral care, cosmeceutical, wound care and others. It features a biocompatible, shelf-stable solution that is currently commercialized in the United States, Europe, India, China and Mexico and select Middle East countries under various country specific regulatory clearances and approvals. Several solutions derived from this platform have demonstrated, in a variety of research and investigational studies, the ability to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi and spores; increase blood flow to the wound site; and reduce both inflammation and pain while assisting in faster wound closure. The company's headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America.
|
|
|
Who are Oculus Innovative Science customers?
This depends in large part on which part of the world you're in. In the United States, it is currently a mix of wound care doctors/nurses, dermatologists, veterinarians, podiatrists, pediatricians, pet owners and individuals who are using various wound care, surgical and dermatology products formulated from Microcyn Technology.
In Mexico, Microdacyn60 has been approved by the Mexican Ministry of Health as a disinfectant, antiseptic and sterilant for use by surgeons, doctors, podiatrists and patients for the treatment of complex wounds, such as burns and diabetic foot ulcers. As well, Mexican dermatologists are now using a GramaDerm HydroGel for the treatment of acne.
Other customers include partners or licensees who may come under agreement to package and market Microcyn Technology via private label such is the case in India, where Alkem Laboratories is distributing a wound care product under the brand name of Oxum. Distributors or sales partners are also selling Microcyn-based products in China, Europe and in select Middle East countries.
|
|
|
When was Oculus Innovative Sciences founded?
We were incorporated in California in 1999 as Micromed Laboratories, Inc. In August 2001, we changed our name to Oculus Innovative Sciences, Inc. In December 2006, we reincorporated in Delaware.
|
|
|
Where is Oculus located?
Our principal executive offices are located at:
1129 N. McDowell Blvd.
Petaluma, California
94954
and our telephone number is (707) 782-0792.
We have a subsidiary: Oculus Technologies of Mexico, S.A. de C.V., organized in Mexico.
|
|
|
How many employees does Oculus have?
As of March 2011, 56 full-time employees globally.
|
|
|
When was Oculus Innovative Sciences' initial public offering, and what was the offering price?
Oculus Innovative Sciences, Inc. went public on January 25, 2007 and the offering price was $8.00 per share.
|
|
|
What is the company's CUSIP number?
Oculus' CUSIP number is 67575P10
|
|
|
What is Oculus' stock symbol and on what stock exchange is it listed?
Oculus' stock symbol is OCLS and is listed on the Nasdaq Global Market system.
|
|
|
Which analysts currently follow the company?
Oculus Innovative Sciences is currently followed by: Robert Wasserman of Dawson James Securities; Stephen M. Dunn of LifeTech Capital; Ross Silver of Vista Partners; and Suraj Kalia of Rodman & Renshaw
The above may not be a complete list of brokerage firms or analysts following our common stock, and this list is subject to change. Any opinions, estimates, forecasts or predictions regarding Oculus' historical or projected performance made by analysts are theirs alone and do not represent the opinions, estimates, forecasts or predictions of Oculus' or its management. We are providing this information as a service to our stockholders, and the inclusion of this list on our website does not imply our endorsement of or concurrence with any information, conclusions or recommendations in the analysts' reports. We do not distribute analysts' reports. Some of the firms listed above may be market-makers in our stock or hold long or short positions in our stock, and may provide services to us for which they are compensated.
|
|
|
When is Oculus' fiscal quarter and year-end dates?
Oculus operates on a fiscal year ending March 31st. Our quarterly reporting periods end on June 30th, September 30th, December 31st and March 31st.
|
|
|
Who is Oculus' transfer agent and how does a registered shareholder contact the agent regarding account information?
Oculus' transfer agent is:
Mellon Investor Services LLC
Oculus Innovative Sciences
P.O. Box 3316
So. Hackensack, NJ 07606
(888) 647-8901
|
|
|
If I own certificated shares of Oculus and have misplaced my stock certificate, what can I do?
You can contact Oculus' transfer agent, Mellon Investor Services LLC.
|
|
|
I've recently moved. How do I submit my new address?
You must contact our transfer agent, Mellon Investor Services LLC.
|
|
|
Who are the auditors of Oculus Innovative Sciences?
Marcum & Kliegman LLP, New York, New York
|
|
|
Who is the company's outside legal counsel?
Amy Trombly, Esq.
Trombly Business Law, PC
1320 Centre St., Ste 202
Newton, Massachusetts 02459
(617) 243-0060
|
|
|
Does Oculus currently offer a direct stock purchase plan?
The company does not offer a direct stock purchase program.
|
|
|
Does Oculus pay a cash dividend on its shares of common stock?
We have never paid our stockholders cash dividends, and we do not anticipate paying any cash dividends in the foreseeable future as we intend to retain any earnings for use in our business.
|
|
|
Who are the Oculus Officers & Directors?
Oculus's officers and directors can be found on the Corporate Governance page of the investor relations Web site.
|
|
|
How can I contact someone at Oculus with a question or request?
Please visit the Contact Us page on the Company website. Email addresses for specific questions and concerns are provided. Additionally, Oculus can be reached by calling 707-782-0792.
|
|
|
How can I find information on Oculus's SEC filings?
Oculus's SEC filings can be obtained by visiting SEC Filings page or www. sec.gov.
|
|
|
Who handles investor relations for Oculus?
Investor relations is handled by Oculus' internal staff. For additional information, please contact Dan McFadden at (425) 753-2105 or dmcfadden@oculusis.com
|
|
|
